ARCHIVES

Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote

This article is from The Cancer Letter archive.

Vol. 02 No. 14 | April 2, 1976

Download PDF Visit The Full Archive

Related Articles

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

St. Jude Offers Two Fellowships

July 18, 1986

Female Smokers Face Double Risk For Lung Cancer

July 28, 2006

Rauscher For Cancer Program

May 20, 1977

Niederhuber Leads AACI

November 2, 2001

Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent

September 18, 1998